Integrated genomic analyses of ovarian carcinoma
2011 · Nature · 7,962 citations
https://doi.org/10.1038/nature10166
S
Steve E. Kalloger
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
290
Papers
22.8K
Citations
58
h-index
102
i10-index
Steve E. Kalloger is an academic researcher. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Pancreatic and Hepatic Oncology Research & Cancer Genomics and Diagnostics. The author has an h-index of 58, co-authored 247 publications.
ORCID: 0000-0003-1332-7881Papers by this author
worksOvarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
2008 · BMC Cancer · 284 citations
https://doi.org/10.1186/1471-2407-8-17
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with <scp>HER2</scp> targeting in 19% of carcinomas
2012 · The Journal of Pathology · 195 citations
https://doi.org/10.1002/path.4088
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
2014 · BMC Cancer · 78 citations
https://doi.org/10.1186/1471-2407-14-120
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
2007 · BMC Medicine · 64 citations
https://doi.org/10.1186/1741-7015-5-33
The autophagy protein <scp>LC3A</scp> correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer
2012 · The Journal of Pathology · 54 citations
https://doi.org/10.1002/path.4090
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat